Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer
Clinical trial NCT02830282 · COMPLETED
Trial details
- NCT number
- NCT02830282
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-07-01
- Primary completion
- 2018-03-16
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.